Chargement en cours...
Rifaximin therapy and hepatic encephalopathy: Pros and cons
Hepatic encephalopathy (HE) is the second most common major complication in cirrhotics and it significantly impacts quality of life. Therapeutic approaches for HE treatment and prevention mainly continue to rely on ammonia-lowering strategies and non-absorbable disaccharides are currently considered...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Baishideng Publishing Group Co., Limited
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3437447/ https://ncbi.nlm.nih.gov/pubmed/22966484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4292/wjgpt.v3.i4.62 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|